|
NRI Dr. Deepak
Srivastava & Dr. Vidu Garg- Uncover Heart Defect Gene
(Specific gene mutations responsible for congenital
heart defects)
DALLAS July 6, 2003 Researchers at UT
Southwestern Medical Center at Dallas have discovered a gene critical
to the development of the human heart and that mutations in the
gene lead to congenital heart defects the leading noninfectious
cause of death in newborns GATA4 is only the second gene to have
been identified as a cause of isolated congenital heart disease
not associated with medically identified syndromes.
The findings will be published in a future edition of the journal
Nature and appear online today.
The researchers identified mutations in the gene GATA4 as a cause
of human cardiac septal defects, which occur when the walls separating
the heart's four chambers do not form properly.
"In terms of identifying genetic etiologies, there are not
many discoveries that have been made," said Dr. Vidu Garg,
assistant professor of pediatrics and one of the study's lead authors.
"This is one of the genes responsible, and we are working to
identify others."
This discovery could one day help doctors prevent congenital heart
defects the most common developmental anomaly by fixing
the problem before a baby is born, said Dr. Deepak Srivastava, associate
professor of pediatrics and molecular biology and the study's senior
author.
"We cannot change the fact that parents are going to pass
along the mutation, but we might be able to develop a way to keep
the disease from occurring," said Dr. Srivastava.
In the Nature study, researchers from UT Southwestern and three
Japanese medical institutions examined two large families: one in
Dallas that spanned five generations and included 16 members suffering
from congenital heart defects, and a family from Tokyo spanning
four generations and with eight members with congenital heart defects.
UT Southwestern researchers and Dr. Rumiko Matsuoka, a pediatric
cardiologist from Japan, gathered data from the families' medical
history. Researchers also conducted physical examinations, electrocardiograms
and cardiac ultrasounds. Genomic DNA from white blood cells was
used for analysis, and researchers studied medical records of family
members who had died.
Researchers performed a genetic linkage analysis. The analysis
helps researchers find the responsible genes by comparing the genetic
codes of patients suffering from heart defects with the codes of
those who did not.
GATA4 mutations showed up in all family members with heart disease
but not in the family members without heart disease or in 3,000
unrelated individuals.
The gene may be responsible for the defects through its interaction
with TBX5, a protein that causes a subset of syndromic cardiac septal
defects. Irfan Kathiriya, a student in UT Southwestern's Medical
Scientist Training Program and co-lead author, found that when a
single amino of GATA4 was altered in the Dallas family, it prevented
GATA4 from associating with TBX5, suggesting that the two work together
to divide the heart into four chambers.
Dr. Srivastava said the next step is to determine how common GATA4
mutations are in the general population of children with heart defects
and use that information to devise clever approaches to prevention.
Eventually, broad screenings of individuals with congenital heart
defects may help prepare them for the possibility of having a child
with congenital heart defects, Dr. Garg said. The risk of that happening
if either parent has a GATA4 mutation is 50 percent. In general,
the risk of having a child with congenital heart disease is about
1 percent and jumps to 5 percent for parents who already have a
baby with congenital heart disease.
Other UT Southwestern researchers who worked on the study were
Dr. Jonathan Cohen, associate professor of internal medicine; Robert
Barnes, a programmer analyst in the Eugene McDermott Center for
Human Growth and Development; Marie Schluterman, a research technician
in pediatrics; Dr. Isabelle King, a fellow in pediatrics; Caryn
Rothrock, a biochemistry student research assistant; and Dr. Reenu
Eapen, assistant professor of pediatrics. Cheryl Butler, a registered
nurse at Children's Medical Center of Dallas, also worked on the
study.
Researchers from the Tokyo Women's Medical University, the Heart
Institute of Japan and Kyusyu Kosei-Nenkin Hospital in Fukuoka also
took part in the study.
The study was funded by the National Institute of Child Health
and Human Development; the National Heart, Lung and Blood Institute;
the March of Dimes Birth Defects Foundation; Smile Train Inc.; and
the Grant for the Promotion of the Advancement of Education and
Research in Graduate Schools in Japan.
|